PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.33M | 18.29M | 18.92M | 19.98M | 20.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.21M | 85.51M | 84.88M | 82.17M | 78.23M |
| Operating Income | -86.21M | -85.51M | -84.88M | -82.17M | -78.23M |
| Income Before Tax | -79.91M | -84.90M | -82.99M | -79.17M | -74.81M |
| Income Tax Expenses | -2.17M | -2.20M | -2.12M | -18.30M | -16.10M |
| Earnings from Continuing Operations | -77.74 | -82.71 | -80.87 | -60.88 | -58.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.74M | -82.71M | -80.87M | -60.88M | -58.71M |
| EBIT | -86.21M | -85.51M | -84.88M | -82.17M | -78.23M |
| EBITDA | -86.07M | -85.37M | -84.40M | -81.35M | -77.08M |
| EPS Basic | -1.48 | -1.58 | -1.56 | -1.18 | -1.14 |
| Normalized Basic EPS | -0.95 | -0.94 | -0.92 | -0.88 | -0.82 |
| EPS Diluted | -1.48 | -1.58 | -1.56 | -1.18 | -1.14 |
| Normalized Diluted EPS | -0.95 | -0.94 | -0.92 | -0.88 | -0.82 |
| Average Basic Shares Outstanding | 210.16M | 208.77M | 207.35M | 206.82M | 206.31M |
| Average Diluted Shares Outstanding | 210.16M | 208.77M | 207.35M | 206.82M | 206.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |